Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen最新文献

筛选
英文 中文
An overview of proposed mechanisms of specific immunotherapy (SIT). 特异性免疫治疗(SIT)机制概述。
Thomas A E Platts-Mills
{"title":"An overview of proposed mechanisms of specific immunotherapy (SIT).","authors":"Thomas A E Platts-Mills","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"97 ","pages":"115-8"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32410578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin-5+ super-effector Th2 cells as targets for immunotherapy and drug discovery. 白细胞介素-5+超效应Th2细胞作为免疫治疗和药物发现的靶点。
Calman Prussin
{"title":"Interleukin-5+ super-effector Th2 cells as targets for immunotherapy and drug discovery.","authors":"Calman Prussin","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"97 ","pages":"124-7"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32410581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvants and vector systems for the sublingual route. 舌下途径的佐剂和载体系统。
Philippe Moingeon, Véronique Bodo, Sabi Airouche, Laurent Mascarell, Thierry Batard
{"title":"Adjuvants and vector systems for the sublingual route.","authors":"Philippe Moingeon, Véronique Bodo, Sabi Airouche, Laurent Mascarell, Thierry Batard","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"97 ","pages":"164-7"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32410588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sublingual immunotherapy: overview of American experience. 舌下免疫治疗:美国经验综述。
Paul A Greenberger
{"title":"Sublingual immunotherapy: overview of American experience.","authors":"Paul A Greenberger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>SLIT remains under investigation in the United States. It is anticipated that many patients, who suffer from intermittent (seasonal) or persistent (perennial) allergic rhinitis, would be interested in SCIT as an immunomodulatory therapy. Not all of the future SLIT patients seek professional advice for diagnosis and treatment of allergic rhinitis or have so previously and are dissatisfied with the necessity to use or cannot tolerate pharmacotherapy. Effective SLIT (as for SCIT) requires an accurate diagnosis of IgE mediated allergic rhinitis or asthma, and it is well known that many patients are not correct when predicting what their own allergies are. The same goes for some general practice health care professionals as well!</p>","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"97 ","pages":"177-9"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32410590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State-of-the-art allergoids: overview of clinical trials. 最先进的类过敏原:临床试验综述。
Sabina Rak
{"title":"State-of-the-art allergoids: overview of clinical trials.","authors":"Sabina Rak","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"106-9; discussion 109-11"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29272230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of molecular allergens for in vitro testing: a critical evaluation of component-resolved diagnostics. 分子过敏原对体外测试的重要性:对成分分解诊断的关键评估。
Jonas Lidholm
{"title":"The importance of molecular allergens for in vitro testing: a critical evaluation of component-resolved diagnostics.","authors":"Jonas Lidholm","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"157-61; discussion 161-3"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29272236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Responsibilities and new challenges for EDQM and the OMCL Network. EDQM和OMCL网络的责任和新挑战。
Karl-Heinz Buchheit
{"title":"Responsibilities and new challenges for EDQM and the OMCL Network.","authors":"Karl-Heinz Buchheit","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"167-71"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29272237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A global view of allergenic product potency. 致敏产品效力的全球观点。
Jay E Slater
{"title":"A global view of allergenic product potency.","authors":"Jay E Slater","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"178-85; discussion 185-6"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29272239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trials with recombinant allergens--three perspectives: industry. 重组过敏原的临床试验——三个角度:工业。
Annemie Narkus, Frans Kniest, Anja Menzel, Hanns Meyer, Viola Sprung
{"title":"Clinical trials with recombinant allergens--three perspectives: industry.","authors":"Annemie Narkus,&nbsp;Frans Kniest,&nbsp;Anja Menzel,&nbsp;Hanns Meyer,&nbsp;Viola Sprung","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"270-5; discussion 275-8"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29273202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel multi-potential dendritic cell targeted gene vaccination platform; application to food allergy and beyond. 一种新型多电位树突状细胞靶向基因疫苗接种平台适用于食物过敏及其他。
Ke Zhang, Anne Behnecke, Wei Li, Andrew Saxon
{"title":"A novel multi-potential dendritic cell targeted gene vaccination platform; application to food allergy and beyond.","authors":"Ke Zhang,&nbsp;Anne Behnecke,&nbsp;Wei Li,&nbsp;Andrew Saxon","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88824,"journal":{"name":"Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen","volume":"96 ","pages":"338-47; discussion 348"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29270421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信